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Abstract
Mycobacterium avium subspecies paratuberculosis (MAP) asymptomatic infection has been previously linked to Type 1
diabetes (T1D) and Multiple Sclerosis. An association between MAP infection and Hashimoto’s thyroiditis (HT) was also
proposed only in a case report. This study aimed to investigate the robustness of the latter association, testing a large
cohort of HT and healthy control (HCs) subjects, all from Sardinia. Prevalence of anti-MAP3865c Abs was assessed by indirect
enzyme-linked immunosorbent assay (ELISA). Moreover, given that human ZnT8 is specifically expressed in the pancreatic b-
cells, in the follicle epithelial cells and in the parafollicular cells of the thyroid gland, we also tested ZnT8 epitopes
homologues to the MAP3865c immunodominant peptides previously identified. Indeed, Abs targeting MAP3865c and ZnT8
homologous regions display similar frequencies in patients and controls, thus suggesting that Abs recognizing these
epitopes could be cross-reactive. A statistically significant difference was found between HT patients and HCs when
analyzing the humoral response mounted against MAP3865c/ZnT8 homologues epitopes. To our knowledge, this is the first
report, which provides statistically significant evidence sustaining the existence of an association between MAP sero-
reactivity and HT. Further studies are required to investigate the relevance of MAP to HT, aimed at deciphering if this
pathogen can be at play in triggering this autoimmune disease. Likewise, genetic polymorphism of the host, and other
environmental factors need to be investigated.
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Introduction
Hashimoto’s thyroiditis (HT) is a chronic inflammatory
condition affecting the thyroid gland. The hallmark of this disease
is the abundant lymphocyte B and T infiltrate, resulting in thyroid
destruction. It involves both humoral and cellular responses
against two thyroid autoantigens: thyroid peroxidase (TPO) and
thyroglobulin (TG) [1]. HT is a multifactorial disease stemming
from an interaction between genetic and environmental risk
factors [2,3]. It has been proposed that Mycobacterium avium
subspecies paratuberculosis (MAP) may be one of the environmental
factor at play in triggering HT disease [4,5], but the assumption
made was not supported by statistically significant data.
MAP specifically colonizes the mucosa-associated lymphoid
tissue (MALT) of the small intestine, where it resides inside the
intraepithelial macrophages [6] causing Johne’s disease (JD) in
ruminants [7] and it is associated with Crohn’s disease (CD) in
humans [8]; moreover, it has been linked to some extradigestive
diseases such as type 1 diabetes (T1D) [9–11] and multiple
sclerosis (MS) [6,12]. Indeed, an increased serological prevalence
of anti-MAP antibodies (Abs) have been reported in T1D patients
from Sardinia [9–11], from continental Italy [12], elsewhere [13],
and in MS Sardinian subjects [14].
Sera from all the participants included in this case-control study
(107 HT patients and 100 HCs) were tested by indirect enzyme-
linked immunosorbent assay (ELISA) in order to investigate the
prevalence of anti-MAP3865c and anti-ZnT8 antibodies in
Sardinia. Abs produced in reaction to MAP3865c peptides are
capable of cross-reacting with the homologue ZnT8 peptides of
the human body, including the ones located in the thyroid tissue.
Indeed, ZnT8 is primarily expressed in the pancreatic b-cell, but it
is also specifically expressed in the follicle epithelial cells and
parafollicular cells of the thyroid gland [15]. In view of the
evidence accounting for a cross-recognition of MAP3865c/ZnT8
homologues sequences in T1D subject [9,10,12] and due to the
recently proposed theory which pictures MAP as one of the HT
environmental trigger, acting trough a molecular mimicry
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mechanism [4,5], we decided to investigate the sero-prevalence of
anti-MAP/ZnT8 Abs among Sardinian HT patients. To date, this
is the first study producing experimental evidence accounting for
an association between MAP presence and HT disease.
Material and Methods
Subjects
The participants enrolled in this case-control study were 107
individuals affected by Hashimoto’s thyroiditis (n = 107; 9 male, 98
female; mean age 45.2614.6 years), and 100 age and sex-matched
healthy controls (HCs). HC subjects were blood donors at the
University Hospital of Sassari, with no history of autoimmune
disease. All the HT subjects enrolled were attending the
Endocrinology Unit of the University Hospital of Sassari, Italy
and were diagnosed either according to their history of hypothy-
roidism with positive antithyroid antibodies, or when there was a
diffuse lymphocytic infiltration bilaterally on the pathology report.
Patient’s details are provided in Table 1. Serum samples were
collected from Vacutainer serum tubes.
Ethical statement
All participants signed an informed consent to be enrolled in our
study. The study protocols were approved by the ethics committee
of the University Hospital of Sassari, Italy.
Peptides
Peptides MAP3865c125–133 (MIAVALAGL) andMAP3865c133–141
(LAANFVVAL) along with their respective homologous peptides
ZnT8178–186 (MIIVSSCAV), ZnT8186–194 (VAANIVLTV) and
MAP3865c262–275 (DSARVLRDARAVLS) were synthesized at .
90% purity (LifeTein, South Plainfield, NJ 07080, USA).
ELISA
Indirect ELISAs to detect Abs specific for MAP3865c/ZnT8
homologues peptides and anti-MAP3865c262–275 were carried out
as described elsewhere [9]. Finest cut-off points were identified by
Receiver operating characteristic (ROC) curves analyses, setting
the specificity at 93% (i.e., Ab+ HCs #7% and the corresponding
sensitivity was chosen accordingly. Data was normalized to a
positive control serum included in all essays run, whose Ab-
reactivity was set at 10.000 arbitrary units (AU)/ml.
Auto-antibodies assays
Anti-TPO and anti-TG antibodies titers were measured by
chemiluminescence methodology in the serum of 53 and 51
subjects respectively, using the Liaison Anti-TPO kit (DiaSorin,
Italy) for anti-TPO assay with normal values ranging from 0–
10 unit/ml and the Liaison Anti-Tg kit (DiaSorin, Italy) for anti-
TG assay with normal values ranging from 0–100 units/ml
according to the producer’s instructions.
Statistical analysis
Statistical analyses were performed by Graphpad Prism 6.0
software.
Results
We investigated whether MAP3865c/ZnT8 homologues pep-
tides, which were highly immunogenic in T1D subjects, could be
recognized by HT Sardinian patients. Five MAP3865c/ZnT8
peptides, four belonging to the fourth trans-membrane domain [9]
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(DSARVLRDARAVLS) were examined in 107 HT, and 100 age
matched HCs via our previously set up indirect ELISA [9]. The
five peptides were highly recognized proving detectable reactivity.
Results are summarized in Fig. 1 and Fig. 2.
MAP 3865c125–133 Abs were detected in 26% of HT subjects
and in 7% of HCs, this difference was statistically significant
(Fisher exact test: p=0.0003; area under ROC curves
AUC=0.72; Fig. 1A).
ZnT8178–186 Ab-reactivity was slightly lower than the one
showed by its homologue MAP3865c125133 when comparing HT
with HCs (21% and 6%, respectively; p=0.0022; AUC=0.72;
Fig. 1B).
The homologous MAP3865c133–141 and ZnT8186–194 peptides
(Fig. 1C–D) were recognized by 21% and 20% of HT patients, but
only in 6% of HCs (AUC 0.74 and 0.73 respectively; p=0.0022
for MAP3865c133–141 and p=0.0038 for ZnT8186–194).
Abs against MAP3865c262–275 were detected in 21% of HT and
in 4% of HC subjects, this difference being statistically significant
(Fisher exact test: p=0.0003; AUC=0.74; Fig. 2).
A correlation analysis revealed that there was a high degree of
correlation between titers of Abs recognizing MAP3865c and
ZnT8 homologous sequences in both HT patients and HCs
(Fig. 3). R2= 0.85 for both MAP3865c125–133 vs ZnT8178–186 and
MAP3865c133–141 vs ZnT8186–194 (Fig. 3 A–B). A similar
correlation was found for MAP3865c125–133 vs MAP3865c133–141
and ZnT8178–186 ZnT8186–194 (Fig. 3C–D; r
2 = 0.82 and 0.74,
respectively).
Discussion
MAP asymptomatic infection and sero-reactivity are highly
prevalent amongst T1D and MS Sardinian subjects. The
aforementioned diseases are acknowledged to be among the most
prevalent autoimmune disease in Sardinia (fourth and fifth,
respectively). Indeed, Sardu et al. reported that HT is the most
common autoimmune disease in Sardinia, and that individuals
affected by one autoimmune disease are more likely to develop a
second autoimmune disorder [16]. All of this pointing out that
there might be a common pathogenic mechanism behind these
autoimmune diseases. Besides, MAP has been called forth as a
potential environmental trigger of HT [4,5]. The link between
MAP and HT was postulated after establishing the presence of
viable MAP organism in few Italian subjects suffering from HT
disease. MAP was detected by reverse transcription-PCR [4,5].
The objective of this study was to verify the robustness of the
postulated association investigating whether ZnT8/MAP peptides
could be cross- recognized in HT individuals. We asked whether
Abs against these epitopes may be at play in HT in Sardinian
Figure 1. Scatter plot representation of ELISA values in Hashimoto’s thyroiditis patients compared to healthy controls. Scatter plots
for MAP3865c125–133 (A) and its homologous ZnT8178–186 (B) and MAP3865c133–141 (C) and its homologous ZnT8186–194 (D) representing the IgG
antibodies distribution against these epitopes in Hashimoto’s thyroiditis patients and healthy subjects. The number of serum samples in each group
is indicated. Dotted lines indicate the cutoff, while bars indicate the corresponding median 6 interquartile range. The percent fraction of antibody
positive sera is indicated on top of each distribution, whereas AUC and p values are given in the top right corner.
doi:10.1371/journal.pone.0097621.g001
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subjects. This hypothesis pictures MAP as a new HT environ-
mental trigger, capable of imitating immunogenic components of
the thyroid gland, acting mainly through a molecular mimicry
mechanism. Interestingly, ZnT8 is expressed in pancreatic b-cells
and in the follicle epithelial cells and parafollicular cells lining the
thyroid follicle.
Our study shows that Abs against mycobacterial
(MAP3865c125–133, MAP3865c133–141 MAP3865c281–287) in con-
junction with Abs against human (ZnT8178–186 and ZnT8186–194)
peptides are highly common in HT from Sardinia, but barely
detectable in age and sex matched HCs.
Of note, titers against MAP3865c133–141 and MAP3865c125–133
epitopes were very similar to the one displayed by the human
homologous peptides (ZnT8186–194, and ZnT8178–186) in HT and
healthy subjects, with a percent fraction of Ab+ sera ranging from
20% to 26%.
Indirect ELISAs highlighted a very similar reactivity against
MAP3865c/Znt8 homologues epitopes accounting for an Ab-
mediated cross-recognition. Indeed, correlation analyses confirm
that Abs recognizing homologous MAP3865c/ZnT8 sequences
segregate within the same sera.
Figure 2. Scatter plots representing the IgG antibodies
distribution against MAP3865262–275 C-terminal epitope in
Hashimoto’s thyroiditis patients compared to healthy controls.
Data representation is the same as in Figure 1.
doi:10.1371/journal.pone.0097621.g002
Figure 3. Relationship between titers of MAP3865c and ZnT8-reactive Abs recognizing different epitopes. A significant correlation was
found between titers of IgG antibodies recognizing MAP3865c125–133 and its homologous ZnT8178–186 epitope (A) and MAP3865c133–141 and its
homologous ZnT8186–194 (B). A significant correlation was also observed between MAP3865c125–133 and its consecutive MAP3865c133–141 epitope (C)
and ZnT8178–186 and its consecutive ZnT8186–194 (D).
doi:10.1371/journal.pone.0097621.g003
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The fact that ZnT8 has not been found expressed by medullary
thymic epithelial cells [17], may suggest that negative selection of
ZnT8-reactive T cells may be ineffective.
Therefore, it will be interesting to investigate the existence of
autoreactive effector T-cells capable of recognizing MAP3865c/
ZnT8 homologous sequences. To date, our newly designed C-
terminal peptide MAP3865c262–275 (DSARVLRDARAVLS) pres-
ent a 53% amino acid identity with ZnT8326–340
(DSQVVRREIAKALSK) epitope, which was recently reported
to be a CD4 (+) T cell target in T1D patients [18]. Noteworthy,
this is the first report which significantly associates MAP infection
with HT. It is still early to conclude whether this is due to a loss of
tolerance toward these epitopes, in fact we here provided only
evidence accounting for an association between Abs positivity for
ZnT8 and MAP homologue epitopes in Sardinian HT individuals.
Further studies are clearly needed to test the hypothesis that MAP
may represent an important environmental factor capable of
triggering HT. Likewise, genetic polymorphism of the host and
other environmental factors need to be explored.
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